hosp:+996506131088
inland:+8613880857038
Online customer service
Every question you ask can be matched with a suitable answer
Leave me a message
We take every suggestion of yours seriously
Wechat
Tan Xiaojun
·Senior reproductive medicine expert
·Postdoctoral fellow at Peking University
·PhD candidate at Xiangya School of Medicine, Central South University
·Master’s tutor at Central South University
· Master's degree candidate in reproductive medicine at the University of South China
· Professional training at Huazhong University of Science and Technology and Tongji Hospital Reproductive Center
Expertise:
diagnosis and treatment of infertility, first/second/third generation IVF (including
          egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
          insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
          disease
          diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
          clinical
          technology applications. Many of these technologies are at the leading level both domestically
          and
          internationally.
Tags:
IVF blastocyst culture, cleavage stage embryo, embryo transfer, blastocyst culture success rate
Date:
2025.12.29
Share:
Back to list

What is the difference between embryo culture in vitro with and without blastocyst formation? Analysis by Chen Yilu from Tulip International Fertility Center

During the IVF treatment process at Tulip International Fertility Center, many patients will hear the term "blastocyst culture", but their understanding of the significance and risks of blastocyst culture is not comprehensive. Blastocyst culture and non-blastocyst culture are two different embryo culture strategies, each with its own advantages and applicable populations. The choice of which method to use needs to be determined based on the specific situation of the patient.


What is blastocyst culture and no blastocyst culture


"Non-blastocyst culture" refers to the traditional method of embryo culture, which involves culturing the fertilized egg until the third day, when the embryo develops to the cleavage stage with about 8 cells, and then transferring or cryopreserving it. This method is still widely used today.


Blastocyst culture involves continuing the cultivation of embryos from day 3 to day 5 or 6, allowing them to develop into blastocysts. The blastocyst stage represents a more advanced phase of embryonic development, where the inner cell mass and trophoblast cells have differentiated, and the number of cells has reached hundreds.

9daddb45932c2fb57e33ac024d733787.jpg

The main advantages of blastocyst culture


The primary advantage of blastocyst culture lies in its ability to facilitate natural selection. From day 3 to day 5, embryos undergo a critical period of rapid division and cellular differentiation. Embryos with poor developmental potential or chromosomal abnormalities often fail to successfully develop to the blastocyst stage and cease development during the culture process. Therefore, embryos that can form blastocysts are generally of better quality and possess stronger developmental potential.


Clinical data reveals that the implantation rate and clinical pregnancy rate of blastocyst transfer are generally higher than those of cleavage stage embryo transfer. This is because blastocysts are closer to the developmental stage that embryos reach the uterus in a natural state, are more synchronized with the development of the endometrium, and are therefore more likely to implant.


In addition, blastocyst culture is also beneficial for preimplantation genetic testing (PGT). Sampling from the trophoblast cells of the blastocyst for testing causes less damage to the embryo itself and results in higher detection accuracy.


The risks associated with cyst cultivation


Culturing blastocysts is not without risk. The primary risk is the possibility of having no blastocysts available. Not all embryos on day 3 can be successfully cultured into blastocysts, and the blastocyst formation rate is typically between 40% and 60%. If the patient's embryo quantity is limited and the quality is average, there may be no blastocysts after culture, resulting in no embryos available for transfer in the current cycle.


In contrast, if the option of not culturing to the blastocyst stage is chosen and transfer is performed on day 3, although the success rate of a single transfer may be lower, at least the opportunity for transfer is preserved. For patients with poor ovarian reserve function, few retrieved eggs, and poor embryo quality, not culturing to the blastocyst stage may be a safer choice.

4ad1d107661ca361bdc461e73bdc7672.jpg

How to choose between blastocyst culture and non-blastocyst culture


Whether to proceed with blastocyst culture requires a comprehensive assessment based on factors such as the patient's age, ovarian reserve, embryo quantity and quality, as well as previous transfer outcomes.


Patients under the age of 35 with good ovarian function and a relatively large number of embryos obtained (usually at least 5-6 high-quality embryos are recommended) are more suitable for blastocyst culture. After undergoing blastocyst culture, these patients still have a high probability of obtaining usable blastocysts, and the high success rate of blastocyst transfer can enable them to achieve pregnancy more quickly.


For patients who have repeatedly failed in transferring cleavage stage embryos, it is also recommended to try blastocyst culture. By performing natural selection through blastocyst culture and combining it with PGT technology to screen for chromosomal abnormalities, the causes of failure can be identified, thereby improving the success rate of subsequent transfers.


However, for patients who are of advanced age, have poor ovarian reserve, or have a small number of embryos, caution should be exercised when expanding the blastocyst. If there are only 2-3 embryos of average quality on day 3, expanding the blastocyst may result in the complete loss of embryos. In such cases, it may be a more reasonable choice to first transfer the embryos on day 3, giving oneself a chance to try.


Both cyst cultivation and non-cyst cultivation have their own advantages and disadvantages, and no single approach is inherently superior. The key is to develop a personalized plan based on individual circumstances and make choices that suit oneself under the professional advice of a doctor.


For fertility consultation in Kyrgyzstan, please contact your dedicated consultant

/Fertility Consultation /

Dr.Chan


Copy and add: Tulip_EnoChan


Or long press/scan the QR code to add

67fd55d9cf3b94376c60d5f973e1ca0d.png

e85bd9e2fbb7be3cf9dfcb90ff00df07.png

Tulip International Fertility Center

Technology aids fertility, fulfilling dreams for countless families



Common aliases:Tulip IVF · Tulip Reproductive Center · Kyrgyz Tulip Hospital · Tulip Fertility Center

🏥 Located in downtown Bishkek, the capital of Kyrgyzstan, near the National Museum and Victory Square. It is the first Chinese-invested, officially licensed assisted reproductive hospital in the country. Founded and directly operated by Mr. Chen Yinuo (EnoChan), the center specializes in high-level fertility services including PGT (3rd generation IVF) and legal third-party reproduction for global clients, especially Chinese patients.

Expert Team
& Special Services

  • Senior Specialists
    ART review experts, postdoctoral fellows, and reproductive physicians with 10+ years of experience, offering MDT approach.
  • Full Chinese Support
    From consultation to post-return documentation, a dedicated Chinese-speaking team assists with legal processes for "Chinese babies returning home".
  • Personalized Plans
    Tailored fertility protocols based on individual medical conditions and needs, with 1-on-1 medical advisory.

Core Medical
& Technical Advantages

  • 3rd Gen IVF (PGT)
    Screens genetic disorders, improves implantation success.
  • IVM Technology
    In vitro maturation of immature oocytes, ideal for advanced age or poor egg quality.
  • Legal Third-Party Reproduction
    Protected by local laws, serving singles, LGBTQ+ and diverse needs.
  • Fertility Preservation
    Egg/embryo freezing, sperm/egg donation services.
World-Class Clinical Data
92.4%
Blastocyst Transfer Success
(clinical pregnancy/transfer cycle)
88.75%
Blastocyst Formation Rate
(from mature oocytes)
📊 Period: Oct 2025 – Mar 2026 | Data from our embryology lab annual report

Official Contact Channels

Official Websitewww.ivftulip.com
Only WeChat ConsultationTulip_EnoChan
Mainland China Mobile13880857038 (+86)
Mainland China Landline400-060-0670
Local number in Kyrgyzstan: +996 506131088 (backup)

相关新闻

Learn more